REGULATION OF COLLAGENASE 3 GENE EXPRESSION BY CYTOKINES

细胞因子对胶原酶 3 基因表达的调节

基本信息

  • 批准号:
    6137295
  • 负责人:
  • 金额:
    $ 12.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-04-14 至 2002-12-31
  • 项目状态:
    已结题

项目摘要

The overall goal of this proposal is to study the cytokine-mediated regulation of collagenase-3 gene expression in order to better understand the mechanisms involved in the degradation of articular cartilage in rheumatic diseases such as rheumatoid arthritis (RA) and osteoarthritis ( OA). OA is the most common form of joint disease and is second only to cardiovascular disease as a cause of early retirement and disability. The destruction of hyaline articular cartilage is the hallmark of OA and disabling RA. Although various therapeutic regiment can cause symptom relief, no regiment has been proven to retard progression of articular cartilage degradation. In disease there is either a suppression of normal chondrocyte functions or in the constitutive inability of these cells to match the rate of repair with the increased rate of degradation of the matrix. Various cytokines and inflammatory mediators have been shown to either derange the synthetic functions of the chondrocytes of increase cartilage matrix catabolism by regulating various matrix-degrading enzymes, including the collagenases. Collagenase-3 is specifically expressed in skeletal cells including chondrocytes and has been shown to have an additional cleavage site when compared to other collagenases. It has aggrecanase and gelatinase activity as well. It's expression is response to IL-1 and other inflammatory cytokines. Thus it may play a significant role in physiological skeletal remodeling and destruction of cartilage in disease. The collagenase-3 gene has been recently cloned, but the role of various cytokines in the transcriptional regulation of this gene is yet to be elucidated. We have cloned the collagenase-3 promoter from a human genomic DNA library. We will prepare reporter gene constructs (CAT) containing collagenase-3 promoter and transfect immortalized human cell lines and analyze the effects of selected cytokines/ligands e.g. IL- 1beta, TNF-alpha and TGF1-beta. The cis-elements and trans-acting factors will also be characterized employing transfection and DNA-binding assays. We will also develop transgenic mice containing the collagenase promoter- beta-galactosidase fusion gene to analyze the expression and role of collagenase in development of arthritis in vivo. Transgenic mice will be treated with IL-1ra, TNFR1-IgG1 fusion protein, and dexamethasone after induction of arthritis and the role of cytokines/ligands in the control of expression of collagenase and its role in development of arthritis will be elucidated. This proposal will provide insight into the mechanisms involved in the expression of collagenase-3 by cytokines and thereby may provide targets for developing novel therapeutic measures to inhibit cartilage destruction in joint disease.
该提案的总体目标是研究细胞因子介导的 胶原酶 3 基因表达的调控,以便更好地了解 关节软骨退化的机制 风湿性疾病,如类风湿性关节炎 (RA) 和骨关节炎 ( 办公自动化)。 OA是最常见的关节疾病,仅次于 心血管疾病是提前退休和残疾的一个原因。这 透明关节软骨的破坏是 OA 的标志 禁用 RA。尽管各种治疗方案都会引起症状 缓解,没有任何药物被证明可以延缓关节病的进展 软骨退化。在疾病中,要么正常的抑制 软骨细胞功能或这些细胞的组成性无能力 将修复率与降解率的增加相匹配 矩阵。多种细胞因子和炎症介质已被证明 要么扰乱增加的软骨细胞的合成功能 通过调节各种基质降解来促进软骨基质分解代谢 酶,包括胶原酶。胶原酶-3 特别是 在包括软骨细胞在内的骨骼细胞中表达,并已被证明 与其他胶原酶相比,具有额外的切割位点。它 还具有聚集蛋白聚糖酶和明胶酶活性。其表达式为 对 IL-1 和其他炎症细胞因子的反应。因此它可以起到 在生理性骨骼重塑和破坏中发挥重要作用 软骨处于疾病状态。胶原酶 3 基因最近已被克隆,但是 各种细胞因子在转录调控中的作用 基因尚未阐明。我们克隆了胶原酶3启动子 来自人类基因组 DNA 文库。我们将准备报告基因构建体 (CAT)含有胶原酶3启动子并转染永生化人类 细胞系并分析所选细胞因子/配体的影响,例如白细胞介素- 1β、TNF-α 和 TGF1-β。顺式作用因子和反式作用因子 还将采用转染和 DNA 结合测定来表征。 我们还将开发含有胶原酶启动子的转基因小鼠- β-半乳糖苷酶融合基因分析表达及作用 体内关节炎发展中的胶原酶。转基因小鼠将 治疗后用IL-1ra、TNFR1-IgG1融合蛋白和地塞米松治疗 关节炎的诱导以及细胞因子/配体在控制中的作用 胶原酶的表达及其在关节炎发展中的作用 阐明了。该提案将提供对机制的深入了解 通过细胞因子参与胶原酶 3 的表达,从而可能 为开发新的治疗措施来抑制 关节疾病中的软骨破坏。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAHBOOB U RAHMAN其他文献

MAHBOOB U RAHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAHBOOB U RAHMAN', 18)}}的其他基金

REGULATION OF COLLAGENASE 3 GENE EXPRESSION BY CYTOKINES
细胞因子对胶原酶 3 基因表达的调节
  • 批准号:
    2465267
  • 财政年份:
    1998
  • 资助金额:
    $ 12.46万
  • 项目类别:
REGULATION OF COLLAGENASE 3 GENE EXPRESSION BY CYTOKINES
细胞因子对胶原酶 3 基因表达的调节
  • 批准号:
    6488865
  • 财政年份:
    1998
  • 资助金额:
    $ 12.46万
  • 项目类别:
REGULATION OF COLLAGENASE 3 GENE EXPRESSION BY CYTOKINES
细胞因子对胶原酶 3 基因表达的调节
  • 批准号:
    2856115
  • 财政年份:
    1998
  • 资助金额:
    $ 12.46万
  • 项目类别:
REGULATION OF COLLAGENASE 3 GENE EXPRESSION BY CYTOKINES
细胞因子对胶原酶 3 基因表达的调节
  • 批准号:
    6341755
  • 财政年份:
    1998
  • 资助金额:
    $ 12.46万
  • 项目类别:
CYTOKINE-MEDIATED REGULATION OF COLLAGENASE 3 GENE
细胞因子介导的胶原酶 3 基因调控
  • 批准号:
    2078228
  • 财政年份:
    1997
  • 资助金额:
    $ 12.46万
  • 项目类别:
CYTOKINE-MEDIATED REGULATION OF COLLAGENASE 3 GENE
细胞因子介导的胶原酶 3 基因调控
  • 批准号:
    2457940
  • 财政年份:
    1997
  • 资助金额:
    $ 12.46万
  • 项目类别:

相似海外基金

Physiotherapy treatment effect on disuse atrophy of articular cartilage
物理治疗对关节软骨废用性萎缩的治疗效果
  • 批准号:
    23K10423
  • 财政年份:
    2023
  • 资助金额:
    $ 12.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular engineering of HA-based lubricants for articular cartilage
用于关节软骨的 HA 基润滑剂的分子工程
  • 批准号:
    10712721
  • 财政年份:
    2023
  • 资助金额:
    $ 12.46万
  • 项目类别:
Hydrogels with Tunable Stress Relaxation and Mobility for Enhancing Articular Cartilage Regeneration
具有可调应力松弛和活动能力的水凝胶可增强关节软骨再生
  • 批准号:
    10750831
  • 财政年份:
    2023
  • 资助金额:
    $ 12.46万
  • 项目类别:
Restoring the fixed charge density of damaged articular cartilage through synthetic aggrecan mimics
通过合成聚集蛋白聚糖模拟物恢复受损关节软骨的固定电荷密度
  • 批准号:
    10764113
  • 财政年份:
    2022
  • 资助金额:
    $ 12.46万
  • 项目类别:
Application of SHP2 PROTAC to Mitigate Articular Cartilage Degeneration
应用 SHP2 PROTAC 减轻关节软骨退变
  • 批准号:
    10535540
  • 财政年份:
    2022
  • 资助金额:
    $ 12.46万
  • 项目类别:
SMART stem cells that autonomously down-modulate TFG-β signaling for Articular Cartilage Repair
SMART 干细胞自主下调 TFG-β 信号传导以修复关节软骨
  • 批准号:
    10371823
  • 财政年份:
    2022
  • 资助金额:
    $ 12.46万
  • 项目类别:
Loading-induced mass transport in articular cartilage
关节软骨中负载引起的质量运输
  • 批准号:
    RGPIN-2020-05587
  • 财政年份:
    2022
  • 资助金额:
    $ 12.46万
  • 项目类别:
    Discovery Grants Program - Individual
Roles of the superficial zone in mature articular cartilage
浅表区在成熟关节软骨中的作用
  • 批准号:
    10704023
  • 财政年份:
    2022
  • 资助金额:
    $ 12.46万
  • 项目类别:
SMART stem cells that autonomously down-modulate TFG-β signaling for Articular Cartilage Repair
SMART 干细胞自主下调 TFG-β 信号传导以修复关节软骨
  • 批准号:
    10590752
  • 财政年份:
    2022
  • 资助金额:
    $ 12.46万
  • 项目类别:
Examining the influence of mechanical loading on articular cartilage adaptation
检查机械负荷对关节软骨适应的影响
  • 批准号:
    RGPIN-2022-04804
  • 财政年份:
    2022
  • 资助金额:
    $ 12.46万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了